Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
0.1070
-0.0020 (-1.83%)
Jul 31, 2026, 2:57 PM HKT
HKG:8329 Market Cap
HKG:8329 has a market cap or net worth of 179.55 million as of July 31, 2026. Its market cap has decreased by -35.54% in one year.
Market Cap
179.55M
Enterprise Value
90.73M
Revenue
1.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
ChartMarket Cap Chart
Since September 12, 2005, HKG:8329's market cap has decreased from 345.53M to 179.55M, a decrease of -48.04%. That is a compound annual growth rate of -3.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 179.55M | -32.70% |
| Dec 31, 2025 | 266.80M | -2.45% |
| Dec 31, 2024 | 273.51M | -0.61% |
| Dec 29, 2023 | 275.19M | -4.65% |
| Dec 30, 2022 | 288.62M | -7.03% |
| Dec 31, 2021 | 310.43M | -46.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lee's Pharmaceutical Holdings | 618.28M |
| Zhongzhi Pharmaceutical Holdings | 561.34M |
| Wai Yuen Tong Medicine Holdings | 356.60M |
| China NT Pharma Group Company | 355.87M |
| Regent Pacific Group | 268.47M |
| Tianda Pharmaceuticals | 223.60M |
| Extrawell Pharmaceutical Holdings | 217.50M |
| Kontafarma China Holdings | 167.66M |